In celebration of CIRM’s 20th anniversary, we have been reflecting on some of the early projects we supported and their outcomes. This blog is a little different, because it also marks the end of a project. Stem cell lines In 2013 CIRM announced a $32 million project to create a repository of stem cell lines … Continue reading 20 years of CIRM: After spurring new research, CIRM’s iPSC repository closes
Month: May 2025
Gene Therapy for Osteoarthritis Shows Positive Results in Early Trial
Image Credit: Shutterstock Here’s a shocking statistic: in 2020, 7.6% of the world’s population was living with the most common form of arthritis – osteoarthritis (OA). That amounts to 595 million people globally and 32.5 million adults in the U.S. Still no cure That’s a lot of people with painful knees, hips, and other joints. … Continue reading Gene Therapy for Osteoarthritis Shows Positive Results in Early Trial
The evolution of a CIRM-funded therapy for macular degeneration
Image Credit: University of Southern California (USC) Eye Institute Over the last two decades CIRM has supported research and helped advance potential treatments for macular degeneration, one of the leading causes of blindness. Early grants One of the earliest was a 2007 SEED grant to David Hinton, MD, of the University of Southern California (USC). … Continue reading The evolution of a CIRM-funded therapy for macular degeneration